Navigation Links
Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1):

Q3 2008: EUR 1.47, up 5.0% --> up 15.6% in U.S. dollars(2)

First 9 months of 2008: EUR 4.24, up 3.4% --> up 17.5% in U.S. dollars(2)

BRIDGEWATER, N.J., Oct. 31 /PRNewswire-FirstCall/ -- In order to give a representation of our underlying economic performance, we present and explain an adjusted(1) income statement. We also report adjusted net income and adjusted EPS (excluding selected items) in U.S. dollars(2) in order to facilitate comparisons with the majority of major pharmaceutical groups. The consolidated income statement for the first nine months of 2008 is provided in Appendix 5. Consolidated net income for the first nine months of 2008 was EUR 3,669 million, compared with EUR 4,510 million for the first nine months of 2007.

Good third-quarter performance

* Net sales: EUR 6,853m, up 5.5% on a comparable basis (down 2.4%

on a reported basis)

-- Quarterly growth ahead of the pharmaceutical industry

-- Good performance from the Top 15 (up 7.3%), especially Lantus(R)

(up 29.1%)

-- Leading supplier of influenza vaccines in the USA, and launch

of Pentacel(R)

-- 11.5% sales growth in the United States

* Operating income - current(1) up 1.2%, or 14.0% excluding the effect

of exchange rates

-- An improvement of 0.9-point in the ratio of selling and General

expenses to net sales, to 24.1%

* Adjusted net income excluding selected items: EUR 1,923m (up 2.1%),

and EPS EUR 1.47 (up 5.0%)


* Completion of acquisitions of Acambis (vaccines) and Symbion

(nutraceuticals/OTC, Australia)

* Improved offer for Zentiva, with the unanimous backing of Zentiva's

Board of Directors

Regulatory Events

* Multaq(R) (dronedarone) assigned priority review status in the United


* October 23, 2008: recommendation to suspend the marketing authoriz

SOURCE sanofi-aventis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. Sanofi-aventis Teams With HHS Quality Agency to Distribute Consumer Health Materials
2. Sanofi-aventis Named One of Best Employers for Healthy Lifestyles by National Business Group on Health
3. Sanofi-aventis: Encouraging First-Quarter 2008 Results Further Positive Phase III Results for Eplivanserin
4. TechTeam Global Will Provide Multilingual EDC Support Services for sanofi-aventis recherche & developpement
5. Sanofi-aventis Announces 2007 Earnings Ahead of Guidance Sharp Rise in Proposed Dividend
6. Sanofi-aventis Announces a Good Third Quarter Performance; Increase in 2007 full-year earnings growth guidance
7. Sanofi-aventis US Chairman Tim Rothwell Addresses CMSAs Collaborative Practice Summit
8. Sanofi-Aventis renews licenses for Genomatix chip analysis pipeline
9. Hay fever may be best treated with self-adjusted dosing
10. Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended June 30, 2008
11. Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year
Post Your Comments:
(Date:8/31/2015)... ... August 31, 2015 , ... has ... services by test marketing a doctor note service to be made available to ... under $50 for each generated excuse, much less than the average daily pay ...
(Date:8/31/2015)... ... August 31, 2015 , ... The Marietta dentists ... organ transplant issues. The doctors and staff ran a 5K race, the Iron ... Kimmerling DDS and Garrick McGrath DMD sponsored the event to help support projects with ...
(Date:8/30/2015)... ... August 31, 2015 , ... The acknowledgement from Caribbean ... by TripAdvisor earlier in 2015. The island of Providenciales itself received a TripAdvisor ... The Venetian on Grace Bay is offering a special promotion for newlyweds and honeymooners ...
(Date:8/30/2015)... ... 31, 2015 , ... Intellitec Solutions, based in Wilmington, DE, ... 5th & 6th in San Antonio, TX. Dedicated to bringing long term and ... all over the country come to share the latest and greatest in healthcare ...
(Date:8/30/2015)... (PRWEB) , ... August 30, 2015 , ... ... is pleased to announce that Partner Daniel M. Kotin was recently elected to ... exclusive organization constitutes the highest degree of peer recognition and outstanding professionalism. ...
Breaking Medicine News(10 mins):Health News:Verde Pointe Dental Associates Runs a 5K for Enduring Hearts 2Health News:Grace Bay Beach Named a Top Beach Destination for Weddings 2Health News:Intellitec Solutions to feature Microsoft Dynamics GP at AHCA/NCAL 66th Annual Convention & Expo 2Health News:Chicago Personal Injury Lawyer Daniel M. Kotin Elected to the American Board of Trial Advocates 2Health News:Chicago Personal Injury Lawyer Daniel M. Kotin Elected to the American Board of Trial Advocates 3
... Desmond Laurence, of the University of London says that ... that they compensated for any problem that // arises ... contracts that are badly worded and do not make ... British Medical Journal reported that accidental and unintentional injuries ...
... A retired doctor fond of gambling lost pounds 8million in a ... one is // that he is putting the blame on ... is suing for his money back. ,The name of ... drugs giant GlaxoSmithKline had failed to warn patients its medicine Requip ...
... health fraternity is deeply concerned. ,According to a ... full recovery from anorexia nervosa is slow, and women ... risk of death. ,As reported in International Journal ... the Klinik Roseneck Hospital for Behavioral Medicine in Prien, ...
... Centre scientists have unravelled mystery surrounding the leaf ... cancer in // animals. ,Anticancer Research journal ... treating mice with this extract before and after ... expression of a cell receptor associated with invasive ...
... found in Australia, could be used as mosquito repellents, in ... University of Adelaide gave mice the secretions of the dumpy ... minutes compared to 12 minutes for an untreated group, the ... the chemical that is used in commercial mosquito repellents, were ...
... garments that could do much more than just cover the ... // underwear that can smell like vanilla and stockings with ... that have been developed since the textile industry followed the ... with functional food. ,The garments have some additional ...
Cached Medicine News:Health News:Mystery unfolds about the Ginkgo biloba extract! 2Health News:Bio-Functional Garments That Could Revolutionize Fashion Industry 2Health News:Bio-Functional Garments That Could Revolutionize Fashion Industry 3
(Date:8/28/2015)... -- IP Shakti, LLC, today announced that it has changed its ... Logo - ... signifies our transformation into a company focused on patent claim ... claim validity." ... platform, the Company commenced a corporate re-branding initiative in order ...
(Date:8/28/2015)... FARUM, Denmark and ATLANTA ... July 31, 2015 the US Food and Drug Administration (FDA) ... Major Depressive Disorder in adult patients who have failed to ... episode. TMS is a non-invasive technique for stimulating neural tissue ... from Major Depressive Disorder. The procedure has been proven safe ...
(Date:8/28/2015)... 2015 The report "Eubiotics Market by Type (Probiotics, ... and Aquaculture), & by Region ( North America ... , and Rest of the World) - Global Trends and ... Eubiotics was valued at USD 4.62 Billion in 2014 and ... a CAGR of 7.4% from 2015 to 2020. ...
Breaking Medicine Technology:IP Shakti, LLC Changes Company Name to Prediqtus, LLC 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 3Eubiotics Market Worth 7.05 Billion USD by 2020 2Eubiotics Market Worth 7.05 Billion USD by 2020 3Eubiotics Market Worth 7.05 Billion USD by 2020 4Eubiotics Market Worth 7.05 Billion USD by 2020 5
... DIEGO, Sept. 8 ResMed Inc. (NYSE: RMD ... company,s outstanding shares of common stock, payable in the form ... 2010. The new total shares outstanding doubled to 151,388,240 shares, ... the company,s common stock on the New York Stock Exchange ...
... 8 Transgenomic, Inc. (OTC Bulletin Board: ... chief executive officer, will deliver the Company,s corporate presentation ... Conference on Monday, September 13 at 4:55 p.m. EDT. ... in New York City from September 13th – 15th, ...
Cached Medicine Technology:Transgenomic to Present at the Rodman & Renshaw 12th Annual Global Investment Conference 2Transgenomic to Present at the Rodman & Renshaw 12th Annual Global Investment Conference 3
Immuno-turbidimetric Assay for Antithrombin III Antigen. Suspension of microlatex particles coated with specific antibodies....
Immuno-turbidimetric assay for Free Protein Sby STA© Analyzers. Suspension of microparticles coated with monoclonal antibodies to Free Protein S....
Substrate Plasma for Factor II Assay by STA© Analyzers. Freeze-dried human serum and absorbed bovine plasma, the latter providing factor V and fibrinogen to the test system....
Substrate Plasma for Factor VIII Assay by STA© Analyzers. Freeze-dried human plasma from which factor VIII has been removed by selective immuno-adsorption....
Medicine Products: